459 related articles for article (PubMed ID: 27812809)
1. Geographic variation in secondary fracture prevention after a hip fracture during 1999-2013: a UK study.
Shah A; Prieto-Alhambra D; Hawley S; Delmestri A; Lippett J; Cooper C; Judge A; Javaid MK;
Osteoporos Int; 2017 Jan; 28(1):169-178. PubMed ID: 27812809
[TBL] [Abstract][Full Text] [Related]
2. Anti-osteoporosis drug prescribing after hip fracture in the UK: 2000-2010.
Klop C; Gibson-Smith D; Elders PJ; Welsing PM; Leufkens HG; Harvey NC; Bijlsma JW; van Staa TP; de Vries F
Osteoporos Int; 2015 Jul; 26(7):1919-28. PubMed ID: 25963232
[TBL] [Abstract][Full Text] [Related]
3. Use of anti-osteoporosis medication dispensing by patients with hip fracture: could we do better?
Kristensen PK; Ehrenstein V; Shetty N; Pedersen AB
Osteoporos Int; 2019 Sep; 30(9):1817-1825. PubMed ID: 31263921
[TBL] [Abstract][Full Text] [Related]
4. [Primary and Secondary Prevention of Hip Fragility Fracture in Teruel Health Sector, Aragon, Spain].
Gómez Navarro R; González García P; Martín Hernández C; Castro Sauras Á; Valdearcos Enguídanos S
Rev Esp Salud Publica; 2017 Jan; 91():. PubMed ID: 28025971
[TBL] [Abstract][Full Text] [Related]
5. Post-fracture care gap: a retrospective population-based analysis of Hong Kong from 2009 to 2012.
Cheung MY; Ho AW; Wong SH
Hong Kong Med J; 2018 Dec; 24(6):579-583. PubMed ID: 30449735
[TBL] [Abstract][Full Text] [Related]
6. Declining rates of osteoporosis management following fragility fractures in the U.S., 2000 through 2009.
Balasubramanian A; Tosi LL; Lane JM; Dirschl DR; Ho PR; O'Malley CD
J Bone Joint Surg Am; 2014 Apr; 96(7):e52. PubMed ID: 24695929
[TBL] [Abstract][Full Text] [Related]
7. Association of Osteoporosis Medication Use After Hip Fracture With Prevention of Subsequent Nonvertebral Fractures: An Instrumental Variable Analysis.
Desai RJ; Mahesri M; Abdia Y; Barberio J; Tong A; Zhang D; Mavros P; Kim SC; Franklin JM
JAMA Netw Open; 2018 Jul; 1(3):e180826. PubMed ID: 30646034
[TBL] [Abstract][Full Text] [Related]
8. Comparison of hip fracture and osteoporosis medication prescription rates across Canadian provinces.
Crilly RG; Kloseck M; Chesworth B; Mequanint S; Sadowski E; Gilliland J
Osteoporos Int; 2014 Jan; 25(1):205-10. PubMed ID: 23907572
[TBL] [Abstract][Full Text] [Related]
9. Oral bisphosphonate prescription and non-adherence at 12 months in patients with hip fractures treated in an acute geriatric unit.
Gamboa A; Duaso E; Marimón P; Sandiumenge M; Escalante E; Lumbreras C; Tarrida A
Osteoporos Int; 2018 Oct; 29(10):2309-2314. PubMed ID: 30076454
[TBL] [Abstract][Full Text] [Related]
10. Low rates of osteoporosis treatment after hospitalization for hip fracture in Hawaii.
Nguyen ET; Posas-Mendoza T; Siu AM; Ahn HJ; Choi SY; Lim SY
Osteoporos Int; 2018 Aug; 29(8):1827-1832. PubMed ID: 29744567
[TBL] [Abstract][Full Text] [Related]
11. Treatment and Management of Osteoporotic Fractures: A Nation-wide Survey of 484 Senior Orthopaedists in China.
Man Y; Pan W; Lu J; Li SY; Zhang P; Guo JZ; Yu SF; Zhang B; Xiao E; Zhang C; Zuo W; Jin HJ; Chen Y; Wu B; Shi XE; Hong D; Liu X; Gao YX; Li J; Yin L; Xue QY
Orthop Surg; 2016 Nov; 8(4):432-439. PubMed ID: 28032704
[TBL] [Abstract][Full Text] [Related]
12. Antiresorptive treatment, when initiated after a first hip fracture, may not protect of a second contralateral episode in elderly population: A study with 685 patients.
Besalduch M; Carrera I; Gómez-Masdeu M; De Caso J
Injury; 2016 Apr; 47(4):877-80. PubMed ID: 26892501
[TBL] [Abstract][Full Text] [Related]
13. What is a reasonable rate for specific osteoporosis drug therapy in older fragility fracture patients?
Gosch M; Bail HJ; Grueninger S; Stumpf U; Kammerlander C; Wicklein S
Arch Osteoporos; 2020 Feb; 15(1):20. PubMed ID: 32088765
[TBL] [Abstract][Full Text] [Related]
14. Anti-osteoporosis medication treatment pattern after osteoporotic fracture during 2010-2016 in Fujian, China.
Wang X; Li C; He Y; Wang T; Zhang H; Ma Z; Ma H; Zhao H
Arch Osteoporos; 2020 Aug; 15(1):134. PubMed ID: 32820451
[TBL] [Abstract][Full Text] [Related]
15. Describing variation in the delivery of secondary fracture prevention after hip fracture: an overview of 11 hospitals within one regional area in England.
Drew S; Sheard S; Chana J; Cooper C; Javaid MK; Judge A;
Osteoporos Int; 2014 Oct; 25(10):2427-33. PubMed ID: 24964893
[TBL] [Abstract][Full Text] [Related]
16. Anti-Osteoporosis Medication Prescriptions and Incidence of Subsequent Fracture Among Primary Hip Fracture Patients in England and Wales: An Interrupted Time-Series Analysis.
Hawley S; Leal J; Delmestri A; Prieto-Alhambra D; Arden NK; Cooper C; Javaid MK; Judge A;
J Bone Miner Res; 2016 Nov; 31(11):2008-2015. PubMed ID: 27377877
[TBL] [Abstract][Full Text] [Related]
17. Visualisation of the unmet treatment need of osteoporotic fracture in Taiwan: A nationwide cohort study.
Wang CY; Fu SH; Huang CC; Hung CC; Yang RS; Hsiao FY
Int J Clin Pract; 2018 Oct; 72(10):e13246. PubMed ID: 30144247
[TBL] [Abstract][Full Text] [Related]
18. [Application of guidelines for secondary prevention of fracture and the FRAX index in patients with fragility fracture].
Naranjo A; Ojeda-Bruno S; Francisco-Hernández F; Erausquin C; Rúa-Figueroa I; Rodríguez-Lozano C
Med Clin (Barc); 2011 Mar; 136(7):290-2. PubMed ID: 21185575
[TBL] [Abstract][Full Text] [Related]
19. Prescription of anti-osteoporosis medications after hospitalization for hip fracture: a multicentre Italian survey.
Gonnelli S; Caffarelli C; Iolascon G; Bertoldo F; Letizia Mauro G; Patti A; Nuti R
Aging Clin Exp Res; 2017 Oct; 29(5):1031-1037. PubMed ID: 27943127
[TBL] [Abstract][Full Text] [Related]
20. [Prescription of osteoporosis drugs and secondary fracture prevention still at low levels and with large regional variation].
Modig K; Meyer A; Ek S; Sääf M; Hedström M
Lakartidningen; 2024 Jan; 121():. PubMed ID: 38343318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
